Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Journal of Ophthalmology

• Publication date

  2010-09-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.2010.179937PMID 20852315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I‐Hurler)

  2012cited by this paper
• Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy – a review

  2010cited by this paper
• Enzyme-Replacement Therapy in a 5-Month-Old Boy With Attenuated Presymptomatic MPS I: 5-Year Follow-up

  2010cited by this paper
• Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study

  2010cited by this paper
• Application of (lamellar) keratoplasty and limbal stem cell transplantation for corneal clouding in the mucopolysaccharidoses – a review

  2010cited by this paper
• Secreted frizzled‐related protein 1 (SFRP1) is highly upregulated in keratoconus epithelium: a novel finding highlighting a new potential focus for keratoconus research and treatment

  2010cited by this paper
• Ocular manifestations in the mucopolysaccharidoses – a review

  2010cited by this paper
• Gene therapy for ocular problems in mucopolysaccharidosis: an experimental and promising approach with benefits in animal models – a review

  2010cited by this paper
• Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004

  2009cited by this paper
• Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I

  2009cited by this paper
• Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients.

  2009cited by this paper
• Mucopolysaccharidosis I: Management and Treatment Guidelines

  2009cited by this paper
• Ocular Features of Treatable Lysosomal Storage Disorders— Fabry Disease, Mucopolysaccharidoses I, II, and VI, and Gaucher Disease

  2009cited by this paper
• Ocular gene therapy: current progress and future prospects.

  2009cited by this paper
• Mucopolysaccharidosis VI: the Italian experience

  2009cited by this paper
• Guidelines for the management of mucopolysaccharidosis type I.

  2009cited by this paper
• Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

  2009cited by this paper
• Pediatric keratoplasty.

  2009cited by this paper
• Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI

  2008cited by this paper
• Effect of gene therapy on visual function in Leber's congenital amaurosis.

  2008cited by this paper
• Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.

  2008cited by this paper
• Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme®) therapy

  2008cited by this paper
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

  2008cited by this paper
• Entering a new treatment age for mucopolysaccharidosis VI disease: a search for better markers of disease progression and response to treatment.

  2008cited by this paper
• Safety and efficacy of gene transfer for Leber's congenital amaurosis.

  2008cited by this paper
• Central corneal thickness and its relationship to intraocular pressure in mucopolysaccararidoses-1 following bone marrow transplantation.

  2008cited by this paper
• High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.

  2007cited by this paper
• Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry.

  2007cited by this paper
• Visual outcome and cataract development after allogeneic stem-cell transplantation in children.

  2007cited by this paper
• Management Guidelines for Mucopolysaccharidosis VI

  2007cited by this paper
• Negative ERGs in mucopolysaccharidoses (MPS) Hurler–Scheie (I-H/S) and Hurler (I-H)-syndromes

  2007cited by this paper
• Dry‐eye syndrome after allogeneic stem‐cell transplantation in children

  2007cited by this paper
• In Vivo Confocal Microscopic Findings of Two Siblings With Maroteaux-Lamy Syndrome

  2007cited by this paper
• Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience.

  2007cited by this paper
• Gene therapy for mucopolysaccharidosis

  2007cited by this paper
• Clinical and Neuroradiological Aspects of the Different Types

  2007cited by this paper
• Mutational analysis of 105 mucopolysaccharidosis type VI patients

  2007cited by this paper
• The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.

  2007cited by this paper
• A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

  2006cited by this paper
• Hunter Syndrome (MPS II-B): A Report of Bilateral Vitreous Floaters and Maculopathy

  2006cited by this paper
• The ocular features of the mucopolysaccharidoses

  2006influential reference
• Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.

  2006cited by this paper
• Ocular findings in four children with mucopolysaccharidosis I-Hurler (MPS I-H) treated early with haematopoietic stem cell transplantation.

  2006cited by this paper
• Mucopolysaccharidoses and the eye.

  2006influential reference
• Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome

  2006cited by this paper
• In Vivo Microstructural Analysis of the Cornea in Maroteaux-Lamy Syndrome

  2005cited by this paper
• The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I

  2005cited by this paper
• Cumulative incidence rates of the mucopolysaccharidoses in Germany

  2005cited by this paper
• The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry

  2005cited by this paper
• Current management of glaucoma

  2004cited by this paper
• Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

  2004cited by this paper
• Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI

  2004cited by this paper
• In Vivo Microstructural Analysis of the Cornea in Scheie's Syndrome

  2003cited by this paper
• Multiple iridociliary cysts in patients with mucopolysaccharidoses.

  2002cited by this paper
• Long-term follow-up of corneal graft survival following bone marrow transplantation in the Maroteaux-Lamy syndrome.

  2001cited by this paper
• Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations

  2001cited by this paper
• Enzyme-replacement therapy in mucopolysaccharidosis I.

  2001cited by this paper
• Corneal transplantation in a patient with mucopolysaccharidosis type VII (Sly disease)

  2000cited by this paper
• Ocular Changes in Mucopolysaccharidosis IV A (Morquio A Syndrome) and Long-Term Results of Perforating Keratoplasty

  1999cited by this paper
• Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI.

  1999cited by this paper
• Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up.

  1998cited by this paper
• Corneal transplantation in Maroteaux-Lamy syndrome.

  1997cited by this paper
• Glaucoma in mucopolysaccharidosis 1-H/S.

  1996cited by this paper
• The mucopolysaccharidoses: a clinical review and guide to management.

  1995influential reference
• Anaesthesia and mucopolysaccharidoses

  1994cited by this paper
• Dense peripheral corneal clouding in Scheie syndrome.

  1994cited by this paper
• Perioperative Management of Children with Mucopolysaccharidoses

  1993cited by this paper
• Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings.

  1993cited by this paper
• Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

  1992cited by this paper
• Macular edema-like change and pseudopapilledema in a case of Scheie syndrome.

  1991cited by this paper
• Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses.

  1990cited by this paper
• Glaucoma in the Maroteaux-Lamy syndrome.

  1989cited by this paper
• Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report.

  1989influential reference
• Glaucoma as an early complication of Hurler's disease.

  1988influential reference
• Mucopolysaccharidoses and anaesthetic risks

  1987cited by this paper
• UVEAL EFFUSION IN HUNTER'S SYNDROME: Evidence That Abnormal Sclera is Responsible For the Uveal Effusion Syndrome

  1986cited by this paper
• Electroretinographic findings in the mucopolysaccharidoses.

  1986cited by this paper
• Occurrence of mucopolysaccharide in corneal grafts in the Maroteaux-Lamy syndrome.

  1985cited by this paper
• Occurrence of mucopolysaccharide in corneal grafts in the Maroteaux-Lamy syndrome.

  1985cited by this paper
• Clearing of cornea after perforating keratoplasty in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)

  1985cited by this paper
• Glaucoma in a case of Hurler disease.

  1980cited by this paper
• Ocular manifestations and pathology of systemic mucopolysaccharidoses.

  1976cited by this paper
• Acute glaucoma in systemic mucopolysaccharidosis I-S.

  1975cited by this paper
• [Scheie's syndrome].

  1973cited by this paper
• Five year maintenance of corneal graft normality in systemic mucopolysaccharidosis.

  1972cited by this paper
• Five year maintenance of corneal graft normality in systemic mucopolysaccharidosis.

  1972cited by this paper

• [Choice of treatment strategy for corneal opacities in patients with mucopolysaccharidosis type VI].

  2025cites this paper
• Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview

  2025cites this paper
• Syndromic Retinitis Pigmentosa: A Narrative Review

  2025cites this paper
• Exploratory metabolomic profiling of plasma and urine in patients with mucopolysaccharidosis type II (Hunter syndrome): A pilot study.

  2025cites this paper
• Mucopolysaccharidosis Type IIIE: A Real Human Disease or a Diagnostic Pitfall?

  2024cites this paper
• Syndromic Retinitis Pigmentosa.

  2024cites this paper
• The diagnosis and management of mucopolysaccharidosis type II

  2024cites this paper
• Pigmented Paravenous Chorioretinal Atrophy and Mucopolysaccharidosis: A Case Report

  2024cites this paper
• Clinical and pathological characterization of ophthalmic disease in a canine model of mucopolysaccharidosis type I

  2023cites this paper
• Ocular management of mucopolysaccharidosis (MPS)

  2023cites this paper
• Biomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI—LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT)

  2023cites this paper
• Late‐onset mucopolysaccharidosis type IIIA mimicking Usher syndrome

  2023cites this paper
• Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice

  2023cites this paper
• Ocular perspective of mucopolysaccharidosis

  2023cites this paper
• Mucopolysaccharidosis

  2023cites this paper
• Mucopolysaccharidosis: A broad review

  2022cites this paper
• Increased ocular wall thickness and decreased globe volume in children with mucopolysaccharidosis type VI

  2022cites this paper
• Management of Corneal Clouding in Patients with Mucopolysaccharidosis

  2021influential citation
• Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

  2021cites this paper
• Mucopolysaccharidosis Type VI, an Updated Overview of the Disease

  2021cites this paper
• Mucopolysaccharidoses

  2021cites this paper
• Angle-closure glaucoma with attenuated mucopolysaccharidosis type I in a Chinese family.

  2021cites this paper
• Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders

  2021cites this paper
• MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment.

  2021cites this paper
• Expanding the phenotype of mucopolysaccharidosis type II retinopathy

  2021cites this paper
• Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases

  2020cites this paper
• Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy

  2020cites this paper
• Mucopolysaccharidosis

  2020cites this paper
• Eye involvement in inherited metabolic disorders

  2020cites this paper
• Retinal changes in mucopolysaccharidosis I- A case report

  2020cites this paper
• Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies

  2020cites this paper
• Multimodal imaging of Hurler syndrome-related keratopathy treated with deep anterior lamellar keratoplasty

  2020cites this paper
• Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue

  2020cites this paper
• Anterior Chamber Angles in Different Types of Mucopolysaccharidoses.

  2020cites this paper
• Ophthalmological Findings in Mucopolysaccharidoses

  2019influential citation
• Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses

  2019cites this paper
• New Frontiers of Corneal Gene Therapy

  2019cites this paper
• Liver transplantation: New treatment for mucopolysaccharidosis type VI in rats

  2018cites this paper
• Deep Anterior Lamellar Keratoplasty in a Case of Hurler–Scheie Syndrome Undergoing Enzyme Replacement Therapy

  2018cites this paper
• Ocular features in mucopolysaccharidosis: diagnosis and treatment

  2018cites this paper
• Evaluation of Cardiovascular Involvement and Cytokine Levels in Patients with Mucopolysaccharidosis

  2018cites this paper
• Involvement of the Anterior Segment of the Eye in Patients with Mucopolysaccharidoses: A Review of Reported Cases and Updates on the Latest Diagnostic Instrumentation

  2017cites this paper
• Ocular Findings in Mucolipidosis Type II.

  2017cites this paper
• Cell Replacement Therapy for Optic Nerve Disorders

  2017cites this paper
• Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment.

  2017influential citation
• Myocardial deformation in pediatric patients with mucopolysaccharidoses: A two‐dimensional speckle tracking echocardiography study

  2017cites this paper
• Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs

  2016cites this paper
• Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective

  2016cites this paper
• Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses

  2016cites this paper
• Degeneration of Photoreceptor Cells in Arylsulfatase G-Deficient Mice.

  2016cites this paper
• The eye and the skin in nonendocrine metabolic disorders.

  2016cites this paper
• Mucopolysaccharidosis Caregiver Quality of Life

  2015cites this paper
• Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses

  2015influential citation
• Assessment and diagnosis of suspected glaucoma in patients with mucopolysaccharidosis

  2015cites this paper
• Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey

  2015cites this paper
• Update on the management of neurometabolic disorders in children

  2014cites this paper
• Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America

  2014cites this paper
• Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI

  2014cites this paper
• Deep anterior lamellar keratoplasty in case of Hurler-Scheie syndrome

  2014cites this paper
• Clinical, Confocal, and Morphological Investigations on the Cornea in Human Mucopolysaccharidosis IH-S

  2014cites this paper
• An update on ocular involvement in mucopolysaccharidoses

  2013cites this paper
• Mucopolysaccharidosis type I and craniosynostosis

  2013cites this paper
• Expert recommendations for the laboratory diagnosis of MPS VI.

  2012cites this paper
• Achados oculares em pacientes com mucopolissacaridoses Ocular findings in patients with mucopolysaccharidosis

  2012cites this paper
• Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis

  2012cites this paper
• Inherited Retinal Degenerations With Systemic Manifestations

  2012cites this paper
• [Ocular findings in patients with mucopolysaccharidosis].

  2011cites this paper
• Achados oculares em pacientes com mucopolissacaridoses

  2011cites this paper
• Ocular manifestations as key features for diagnosing mucopolysaccharidoses.

  2011cites this paper
• Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

  2011cites this paper
• Retinal function in deaf-blind syndromes

  2011cites this paper
• Gene therapy for ocular problems in mucopolysaccharidosis: an experimental and promising approach with benefits in animal models – a review

  2010influential citation
• Application of (lamellar) keratoplasty and limbal stem cell transplantation for corneal clouding in the mucopolysaccharidoses – a review

  2010influential citation
• Ocular manifestations in the mucopolysaccharidoses – a review

  2010cites this paper
• Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy – a review

  2010influential citation
• OPHTHALMIC MANIFESTATIONS IN PATIENTS WITH MUCOPOLYSACC-HARIDOSIS ATTENDING

  year unknowncites this paper